绿新生物科技公布中期业绩 公司拥有人应占亏损1206.8万元 同比盈转亏

Core Viewpoint - Green New Biotechnology (01084) reported a decline in revenue for the first half of 2025, primarily due to decreased sales volume and prices of carrageenan and agar products [1] Financial Performance - Revenue for the first half of 2025 was 410 million yuan, representing a year-on-year decrease of 10.7% [1] - The company reported a loss attributable to shareholders of 12.068 million yuan, marking a shift from profit to loss compared to the previous year [1] - Earnings per share were reported at a loss of 0.014 yuan [1] Product Performance - The decline in revenue was mainly attributed to the reduced sales volume and selling prices of carrageenan and agar products [1]